SEC 13F Intelligence

Balyasny Asset Management L.P. / CONE1EUR

Balyasny Asset Management L.P.’s Co Diagnostics Inc Position

Does Balyasny Asset Management L.P. own Co Diagnostics Inc (CONE1EUR)? Not currently — the last reported position was 1.88M shares worth $168M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$168M
Q4 2021
Shares
1.88M
% of Portfolio
+0.58%
Quarters Held
11
position exited

Position History CONE1EUR

Reported value by quarter
Q1 ’19: $27MQ1 ’19Q2 ’19: $8MQ3 ’19: $4MQ3 ’19Q1 ’20: $30MQ2 ’20: $14MQ2 ’20Q3 ’20: $23MQ4 ’20: $13MQ4 ’20Q1 ’21: $22MQ2 ’21: $32MQ2 ’21Q3 ’21: $41MQ4 ’21: $168MQ4 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20211.88M$168M+0.58%
Q3 2021535.8K$41M+0.17%
Q2 2021451.8K$32M+0.15%
Q1 2021327.4K$22M+0.11%
Q4 2020184.4K$13M+0.07%
Q3 2020324.3K$23M+0.17%
Q2 2020197.1K$14M+0.12%
Q1 2020490.8K$30M+0.36%
Q3 201945.2K$4M+0.02%
Q2 2019144.1K$8M+0.05%
Q1 2019521.0K$27M+0.18%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Balyasny Asset Management L.P.’s full portfolio or all institutional holders of CONE1EUR.